Japanese Team to Begin Tumor Drug Clinical Tests, Sankei Says

A team of researchers at the University of Tokyo will begin clinical tests in France of a drug for cancerous tumors, the Sankei newspaper reported.

OncoTherapy Science Inc. (4564), a Japanese biopharmaceutical company, has been preparing to conduct clinical studies, the newspaper reported, without clarifying whether the company is involved in this particular research.

To contact the editor responsible for this story: Takehiko Kumakura at tkumakura@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.